conjugate
unconjugated
Quality Level
antibody form
purified antibody
clone
I19-18
monoclonal
purified by
using protein G
species reactivity
mouse, human
concentration
(Please refer to lot specific datasheet.)
technique(s)
flow cytometry: suitable
immunocytochemistry: suitable
western blot: suitable
isotype
IgG1κ
UniProt accession no.
target post-translational modification
unmodified
General description
GST-tagged recombinant full-length human SAMHD1.
~72 kDa observed. 72.2 kDa (isoform 1), 69.4 kDa (isoform 2), 63.7 kDa (isoform 3), 68.1 kDa (isoform 4) calculated.
Application
Flow Cytometry Analysis: A representative lot detected a downregulated SAMHD1 immunoreactivity among cutaneous T cell lymphoma (CTCL) patients-derived CD4+ PBMCs when comparing to CD4+ PBMCs from healthy donors (de Silva, S., et al. (2014). J. Invest. Dermatol. 134(2):562-565).
Flow Cytometry Analysis: A representative lot detected SAMHD1 immunoreactivity in CD123+ plasmacytoid dendritic cells (pDCs) from human PBMCs and a downregulated SAMHD1 immunoreactivity in pDCs when cocultivated with PHA–IL-2-activated CD4+ T cells (Su, B., et al. (2014). J. Virol.88(18):10975-10981).
Flow Cytometry Analysis: A representative lot detected SAMHD1 immunoreactivity in non-infected monocyte-derived dendritic cells (MDDCs) and a greatly reduced SAMHD1 immunoreactivity in MDDCs exposed to virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Puigdomènech, I., et al. (2013). J. Virol.87(5):2846-2856).
Western Blotting Analysis: A representative lot detected SAMHD1 in lysates from non-infected monocyte-derived dendritic cells (MDDCs), but not in MDDCs exposed to virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Puigdomènech, I., et al. (2013). J. Virol.87(5):2846-2856).
Immunocytochemistry Analysis: 2.0 µg/mL from a representative lot detected SAMHD1 in THP-1 cells.
Western Blotting Analysis: A representative lot detected a downregulation of intracellular SAMHD1 in primary human dendritic cells (DCs) following infection by virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Courtesy of Dr. Olivier Schwartz, Institut Pasteur, Paris, France).
Immunocytochemistry Analysis: 1.0 µg/mL from a representative lot detected SAMHD1 expression in THP1 human monocytic cells by fluorescent immunocytochemistry (Courtesy of Dr. Olivier Schwartz, Institut Pasteur, Paris, France).
Flow Cytometry Analysis: 0.4 µg/mL from a representative lot detected a downregulation of intracellular SAMHD1 in primary human dendritic cells (DCs) following infection by virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Courtesy of Dr. Olivier Schwartz, Institut Pasteur, Paris, France).
Flow Cytometry Analysis: A representative lot detected a downregulated SAMHD1 immunoreactivity among CD4+ PBMCs 5 days post infection by a laboratory-adapted HIV-2 strain (ROD) or by two other HIV-2 isolates (TOE and ROK) from infected patients (Chauveau, L., et al. (2015). Retovirology. 12:2).
Western Blotting Analysis: A representative lot detected a downregulation of intracellular SAMHD1 in primary human dendritic cells (DCs) following infection by virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Courtesy of Dr. Olivier Schwartz, Institut Pasteur, Paris, France).
Immunocytochemistry Analysis: 1.0 µg/mL from a representative lot detected SAMHD1 expression in THP1 human monocytic cells by fluorescent immunocytochemistry (Courtesy of Dr. Olivier Schwartz, Institut Pasteur, Paris, France).
Flow Cytometry Analysis: 0.4 µg/mL from a representative lot detected a downregulation of intracellular SAMHD1 in primary human dendritic cells (DCs) following infection by virion-like particles (VLPs) generated from wild-type SIV-3 (simian immunodeficiency virus type 3)-positive plasmid (Courtesy of Dr. Olivier Schwartz, Institut Pasteur, Paris, France).
Flow Cytometry Analysis: A representative lot detected a downregulated SAMHD1 immunoreactivity among CD4+ PBMCs 5 days post infection by a laboratory-adapted HIV-2 strain (ROD) or by two other HIV-2 isolates (TOE and ROK) from infected patients (Chauveau, L., et al. (2015). Retovirology. 12:2).
Physical form
Purified mouse monoclonal IgG1κ antibody in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
Preparation Note
Stable for 1 year at 2-8°C from date of receipt.
Analysis Note
Evaluated by Western Blotting in THP-1 cell lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected SAMHD1 in 10 µg of THP-1 cell lysate.
Western Blotting Analysis: 0.5 µg/mL of this antibody detected SAMHD1 in 10 µg of THP-1 cell lysate.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage Class Code
10 - Combustible liquids
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Global Trade Item Number
SKU | GTIN |
---|---|
MABF933 | 04055977311907 |
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service